Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen adjunctive therapy for COVID-19 recovery and mortality
IRCT20200410047009N1Phase 4Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of naproxen in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Length of recovery period. Started Apr 2020; status: completed.
02
Drugs
naproxen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200410047009N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200410047009N1.